This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • paclitaxel
  • /
  • PH3 Study of IMGN853 vs Investigator's Choice of C...
Clinical trial

PH3 Study of IMGN853 vs Investigator's Choice of Chemotherapy in Women With FRa+ Adv. EOC, Primary Peritoneal or Fallopian Tube Cancer (FORWARD I)

Read time: 2 mins
Last updated:1st Dec 2015
Source: Clinical Trials
Identifier: NCT02631876
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest